Andrés G. Fernández
Ferrer Advanced Biotherapeutics
Small molecules with a big impact on nervous system disorders
New compounds to treat neurodegenerative disorders
New HRI activators to treat type 2 diabetes mellitus
Carrying therapeutic cargoes across the blood-brain barrier to fight DIPG
Dual costimulatory targeting in autoimmune diseases
Cannabidiol as a treatment for mitochondrial disease
A new potent and safe antifibrinolytic agent for the prevention and treatment of hemorrhage
New strategy to combat bacterial infections
A new therapy to treat liver, lung and pancreas disease
Development of new therapeutic approaches for leukemia
Molecular tool to diagnose endometrial cancer
Liver on a Chip platform for toxicology and drug development
Therapeutic gene modulation of MBNL1-2 in myotonic dystrophy
New first-in-class treatment for Alzheimer’s disease
Preclinical development of ITH13001 as a second-generation oral treatment for multiple sclerosis